In that study, NK-92 and NKL cells expressing this CAR exhibited enhanced cytotoxicity and IFN-γ secretion against GBM cell lines or patient-derived GBM stem cells expressing EGF or EGFRvIII. Here, EGF is linked to glioblastoma.